Literature DB >> 20717171

Further delineation of the phenotype of severe congenital neutropenia type 4 due to mutations in G6PC3.

Siddharth Banka1, Elena Chervinsky, William G Newman, Yanick J Crow, Shay Yeganeh, Joanne Yacobovich, Dian Donnai, Stavit Shalev.   

Abstract

Severe congenital neutropenia type 4 (SCN4) is an autosomal recessive condition, which was defined recently with identification of the causative mutations in G6PC3. To date there are only three reports in the literature describing patients with SCN4 with mutations in the G6PC3 gene. We report four individuals with SCN4 who belong to a single large consanguineous kindred. We provide an overview of the non-haematological features of the condition with a focus on the adult phenotype, which has not been previously described in detail. We show that the superficial venous changes seen in SCN4 patients can develop into varicose veins and venous ulcers in adulthood. We review the range of congenital anomalies associated with SCN4. We demonstrate that secundum atrial septal defect, patent ductus arteriosus and valvular defects are the most frequent cardiac anomalies in SCN4. Drawing parallels with type 1 glycogen storage disease, we propose that poor growth of prenatal onset, mild-to-moderate learning disability, primary pulmonary hypertension, delayed or incomplete puberty, hypothyroidism and dysmorphism likely represent features of this syndrome. We also suggest monitoring for lipid anomalies, and kidney and liver function in affected patients. Delineation of the SCN4 phenotype may help in appropriate treatment and management and provide further insights into the pathogenesis of this multisystem disease.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20717171      PMCID: PMC3039503          DOI: 10.1038/ejhg.2010.136

Source DB:  PubMed          Journal:  Eur J Hum Genet        ISSN: 1018-4813            Impact factor:   4.246


  14 in total

1.  The putative glucose 6-phosphate translocase gene is mutated in essentially all cases of glycogen storage disease type I non-a.

Authors:  M Veiga-da-Cunha; I Gerin; Y T Chen; P J Lee; J V Leonard; I Maire; U Wendel; M Vikkula; E Van Schaftingen
Journal:  Eur J Hum Genet       Date:  1999-09       Impact factor: 4.246

Review 2.  Molecular genetics of type 1 glycogen storage disease.

Authors:  A R Janecke; E Mayatepek; G Utermann
Journal:  Mol Genet Metab       Date:  2001-06       Impact factor: 4.797

3.  HLA alleles and haplotypes in the Turkish population: relatedness to Kurds, Armenians and other Mediterraneans.

Authors:  A Arnaiz-Villena; M Karin; N Bendikuze; E Gomez-Casado; J Moscoso; C Silvera; F S Oguz; A Sarper Diler; A De Pacho; L Allende; J Guillen; J Martinez Laso
Journal:  Tissue Antigens       Date:  2001-04

4.  Glycogen storage disease type I: diagnosis, management, clinical course and outcome. Results of the European Study on Glycogen Storage Disease Type I (ESGSD I).

Authors:  Jan Peter Rake; Gepke Visser; Philippe Labrune; James V Leonard; Kurt Ullrich; G Peter A Smit
Journal:  Eur J Pediatr       Date:  2002-08-22       Impact factor: 3.183

5.  A novel G6PC3 homozygous 1-bp deletion as a cause of severe congenital neutropenia.

Authors:  Juan I Aróstegui; José Sánchez de Toledo; Mariona Pascal; Carlos García; Jordi Yagüe; Cristina Díaz de Heredia
Journal:  Blood       Date:  2009-08-20       Impact factor: 22.113

6.  Severe pulmonary arterial hypertension in type 1 glycogen storage disease.

Authors:  Marc Humbert; Philippe Labrune; Gérald Simonneau
Journal:  Eur J Pediatr       Date:  2002-07-31       Impact factor: 3.183

7.  Prevalence of mutations in ELANE, GFI1, HAX1, SBDS, WAS and G6PC3 in patients with severe congenital neutropenia.

Authors:  Jun Xia; Audrey A Bolyard; Elin Rodger; Steve Stein; Andrew A Aprikyan; David C Dale; Daniel C Link
Journal:  Br J Haematol       Date:  2009-09-22       Impact factor: 6.998

8.  Mutations in the glucose-6-phosphatase gene that cause glycogen storage disease type 1a.

Authors:  K J Lei; L L Shelly; C J Pan; J B Sidbury; J Y Chou
Journal:  Science       Date:  1993-10-22       Impact factor: 47.728

9.  Familial pulmonary arterial hypertension, leucopenia, and atrial septal defect: a probable new familial syndrome with multisystem involvement.

Authors:  Ali Dursun; R Koksal Ozgul; Asli Soydas; Tugba Tugrul; Aytemiz Gurgey; Alpay Celiker; Robyn J Barst; James A Knowles; Mansukhani Mahesh; Jane H Morse
Journal:  Clin Dysmorphol       Date:  2009-01       Impact factor: 0.816

10.  A syndrome with congenital neutropenia and mutations in G6PC3.

Authors:  Kaan Boztug; Giridharan Appaswamy; Angel Ashikov; Alejandro A Schäffer; Ulrich Salzer; Jana Diestelhorst; Manuela Germeshausen; Gudrun Brandes; Jacqueline Lee-Gossler; Fatih Noyan; Anna-Katherina Gatzke; Milen Minkov; Johann Greil; Christian Kratz; Theoni Petropoulou; Isabelle Pellier; Christine Bellanné-Chantelot; Nima Rezaei; Kirsten Mönkemöller; Noha Irani-Hakimeh; Hans Bakker; Rita Gerardy-Schahn; Cornelia Zeidler; Bodo Grimbacher; Karl Welte; Christoph Klein
Journal:  N Engl J Med       Date:  2009-01-01       Impact factor: 91.245

View more
  14 in total

1.  Glucose-6-phosphatase-β, implicated in a congenital neutropenia syndrome, is essential for macrophage energy homeostasis and functionality.

Authors:  Hyun Sik Jun; Yuk Yin Cheung; Young Mok Lee; Brian C Mansfield; Janice Y Chou
Journal:  Blood       Date:  2012-01-12       Impact factor: 22.113

2.  Phenotypic heterogeneity and evidence of a founder effect associated with G6PC3 mutations in patients with severe congenital neutropenia.

Authors:  Bradley N Smith; Catherine Evans; Akbar Ali; Phil J Ancliff; Bu'hussain Hayee; Anthony W Segal; Georgina Hall; Zuhre Kaya; Abdul Rauf Shakoori; David C Linch; Rosemary E Gale
Journal:  Br J Haematol       Date:  2012-04-02       Impact factor: 6.998

3.  Survival and differentiation defects contribute to neutropenia in glucose-6-phosphatase-β (G6PC3) deficiency in a model of mouse neutrophil granulocyte differentiation.

Authors:  S Gautam; S Kirschnek; I E Gentle; C Kopiniok; P Henneke; H Häcker; L Malleret; A Belaaouaj; G Häcker
Journal:  Cell Death Differ       Date:  2013-05-17       Impact factor: 15.828

4.  Inflammatory bowel disease and T cell lymphopenia in G6PC3 deficiency.

Authors:  Philippe Bégin; Natalie Patey; Pascal Mueller; Andrée Rasquin; Alain Sirard; Christoph Klein; Elie Haddad; Éric Drouin; Françoise Le Deist
Journal:  J Clin Immunol       Date:  2012-11-20       Impact factor: 8.317

Review 5.  Neutropenia in primary immunodeficiency.

Authors:  Robert Sokolic
Journal:  Curr Opin Hematol       Date:  2013-01       Impact factor: 3.284

Review 6.  Hypothesis: A Novel Neuroprotective Role for Glucose-6-phosphatase (G6PC3) in Brain-To Maintain Energy-Dependent Functions Including Cognitive Processes.

Authors:  Gerald A Dienel
Journal:  Neurochem Res       Date:  2020-08-19       Impact factor: 3.996

7.  Mechanisms of Lower Extremity Vein Dysfunction in Chronic Venous Disease and Implications in Management of Varicose Veins.

Authors:  Joseph D Raffetto; Raouf A Khalil
Journal:  Vessel Plus       Date:  2021-05-29

8.  Adult siblings with homozygous G6PC3 mutations expand our understanding of the severe congenital neutropenia type 4 (SCN4) phenotype.

Authors:  Bridget A Fernandez; Jane S Green; Ford Bursey; Brendan Barrett; Andrée MacMillan; Sarah McColl; Sara Fernandez; Proton Rahman; Krista Mahoney; Sergio L Pereira; Stephen W Scherer; Kym M Boycott; Michael O Woods
Journal:  BMC Med Genet       Date:  2012-11-21       Impact factor: 2.103

9.  Family studies of warts, hypogammaglobulinemia, immunodeficiency, myelokathexis syndrome.

Authors:  David C Dale; Emily Dick; Merideth Kelley; Vahagn Makaryan; Jim Connelly; Audrey Anna Bolyard
Journal:  Curr Opin Hematol       Date:  2020-01       Impact factor: 3.218

Review 10.  The role of neutrophils in host defense and disease.

Authors:  Heather K Lehman; Brahm H Segal
Journal:  J Allergy Clin Immunol       Date:  2020-04-10       Impact factor: 14.290

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.